These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20939683)

  • 1. Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target.
    Choi DK; Koppula S; Choi M; Suk K
    Expert Opin Ther Pat; 2010 Nov; 20(11):1531-46. PubMed ID: 20939683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-BIT Life Sciences' third annual world congress. Anti-neurodegenerative and anti-inflammation biotherapeutics.
    Filep JG
    IDrugs; 2010 Feb; 13(2):73-5. PubMed ID: 20127554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Role and Drug Delivery Potential of Neuroinflammation as a Target in Neurodegenerative Disorders.
    Singh A; Chokriwal A; Sharma MM; Jain D; Saxena J; Stephen BJ
    ACS Chem Neurosci; 2017 Aug; 8(8):1645-1655. PubMed ID: 28719178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey.
    Ivachtchenko AV; Ivanenkov YA; Tkachenko SE
    Expert Opin Ther Pat; 2010 Sep; 20(9):1171-96. PubMed ID: 20716023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin receptors and their antagonists: an update on the patent literature.
    Cirino G; Severino B
    Expert Opin Ther Pat; 2010 Jul; 20(7):875-84. PubMed ID: 20450349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between neuroinflammation and neurodegenerative diseases].
    Qiu AW; Liu Z; Guo J; Peng YP
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):353-8. PubMed ID: 22242402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury.
    Pifarré P; Prado J; Giralt M; Molinero A; Hidalgo J; Garcia A
    J Neurochem; 2010 Feb; 112(3):807-17. PubMed ID: 20002517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retardation of brain aging by chronic treatment with melatonin.
    Bondy SC; Lahiri DK; Perreau VM; Sharman KZ; Campbell A; Zhou J; Sharman EH
    Ann N Y Acad Sci; 2004 Dec; 1035():197-215. PubMed ID: 15681809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases.
    Magrioti V; Kokotos G
    Expert Opin Ther Pat; 2010 Jan; 20(1):1-18. PubMed ID: 20021282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
    Martinez A; Castro A; Dorronsoro I; Alonso M
    Med Res Rev; 2002 Jul; 22(4):373-84. PubMed ID: 12111750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectin inhibitors: a patent review.
    Bedard PW; Kaila N
    Expert Opin Ther Pat; 2010 Jun; 20(6):781-93. PubMed ID: 20408735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation.
    Kinsner A; Pilotto V; Deininger S; Brown GC; Coecke S; Hartung T; Bal-Price A
    J Neurochem; 2005 Nov; 95(4):1132-43. PubMed ID: 16144539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge.
    O'Sullivan JB; Ryan KM; Harkin A; Connor TJ
    J Neuroimmunol; 2010 Mar; 220(1-2):34-42. PubMed ID: 20061033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.
    Van Eldik LJ; Thompson WL; Ralay Ranaivo H; Behanna HA; Martin Watterson D
    Int Rev Neurobiol; 2007; 82():277-96. PubMed ID: 17678967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that oxidative stress is linked to anxiety-related behaviour in mice.
    Rammal H; Bouayed J; Younos C; Soulimani R
    Brain Behav Immun; 2008 Nov; 22(8):1156-9. PubMed ID: 18620042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants.
    Cui K; Luo X; Xu K; Ven Murthy MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):771-99. PubMed ID: 15363603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Lipoxygenase inhibitors: a review of recent developments and patents.
    Pergola C; Werz O
    Expert Opin Ther Pat; 2010 Mar; 20(3):355-75. PubMed ID: 20180620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.